Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Hutchison China MediTech Limited    HCM   KYG4672N1016

HUTCHISON CHINA MEDITECH LIMITED (HCM)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/18/2018 04/19/2018 04/20/2018 04/23/2018 04/24/2018 Date
4475(c) 4590(c) 4645(c) 4650(c) 4675(c) Last
15 587 23 523 10 470 19 177 5 596 Volume
+1.59% +2.57% +1.20% +0.11% +0.54% Change
More quotes
Financials (USD)
Sales 2018 246 M
EBIT 2018 -59,4 M
Net income 2018 -34,5 M
Finance 2018 266 M
Yield 2018 -
Sales 2019 285 M
EBIT 2019 -67,3 M
Net income 2019 -38,4 M
Finance 2019 196 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 16,5x
EV / Sales2019 14,5x
Capitalization 4 324 M
More Financials
Company
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products.It operates through the Innovation Platform and Commercial Platform segments.The Innovation Platform segment relates to... 
Sector
Pharmaceuticals
Calendar
04/27 | 12:00pmShareholder meeting
More about the company
Surperformance© ratings of Hutchison China MediTech L
Trading Rating : - Investor Rating :
More Ratings
Latest news on HUTCHISON CHINA MEDITECH L
04/23HUTCHISON CHINA MEDITECH : Block Admission
PU
04/23HUTCHISON CHINA MEDITECH : Grant of Share Options under Share Option Scheme
PU
04/19AACR 2018 : A semi-mechanistic pharmacokinetic-pharmacodynamic (PK-PD) model of ..
PU
03/15HUTCHISON CHINA MEDITECH : Chi-Med Initiates a Phase Ib/II Proof-of-Concept Tria..
AQ
03/12CHI-MED : Reports Final Results for the Year Ended December 31, 2017 and Updates..
BU
03/07HUTCHISON CHINA MEDITECH LIMITED : annual earnings release
03/06HUTCHISON CHINA MEDITECH : Chi-Med Initiates a Phase Ib/II Proof-of-Concept Tria..
BU
02/23HUTCHISON CHINA MEDITECH : Chi-Med Completes Enrollment of 527 Patients in Pivot..
AQ
02/13HUTCHISON CHINA MEDITECH : Chi-Med Completes Enrollment of 527 Patients in Pivot..
BU
02/05HUTCHISON CHINA MEDITECH : Chi-Med to Announce 2017 Final Results
PU
More news
Sector news : Alternative Medicine
02:20aTAKEDA PHARMACEUTICAL : shares slide 5 percent after revised proposal for Shire
RE
02:05aShire, Takeda reach breakthrough in $64 billion deal talks
RE
04/24Monsanto develops product to deactivate controversial farm chemical
RE
04/24GlaxoSmithKline's Trelegy Ellipta Gets Expanded Indication From FDA
DJ
04/24LONDON MARKETS : FTSE 100 Scores 6th Win In A Row As Oil Shares, Shire Rally
DJ
More sector news : Alternative Medicine
Latest Tweets
04/24My time chasing round Moscow trying to film everything ends soon, and on the ..
11
04/23Zacks: Hutchison China MediTech Limited $HCM Receives Average Rating of “Stro.. 
04/23Hutchison China MediTech : Grant of Share Options under Share Option Scheme .. 
04/19Why, in the song Homeward Bound, is the love lying down while she's waiting f.. 
04/19UK ambassador to Simon Collis is a terror backer as he considers the murde..
7
More tweets
Qtime:609
News from SeekingAlpha
03/12Hutchison China MediTech's (HCM) CEO Christian Hogg on Q4 2017 Results - Earn.. 
03/12Hutchison China Meditech FY2017 revenues up 12%; updates guidance 
03/12Hutchison China Meditech  reports FY results 
03/12JF'S CORE BIOTECH BUYS EDITION 1 VOL : Buying Weakness In 2 Beaten Down Stocks 
03/11WEEK IN REVIEW : China Pharma Deals Top $1.5 Billion For Week 
Chart HUTCHISON CHINA MEDITECH L
Duration : Period :
Hutchison China MediTech L Technical Analysis Chart | HCM | KYG4672N1016 | 4-Traders
Technical analysis trends HUTCHISON CHINA MEDITECH L
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 42,5 $
Spread / Average Target -34%
EPS Revisions
Managers
NameTitle
Christian Hogg Chief Executive Officer & Executive Director
Chi Keung To Chairman
Chig Fung Cheng Chief Financial Officer & Executive Director
Wei Guo Su Executive Director, Chief Scientific Officer & EVP
Edith Shih Secretary & Non-Executive Director